Complications of Therapy and a Diagnostic Dilemma Case
Author:
Affiliation:
1. Departments of Dermatology and Oncology and the Division of Pathology, Istituto Clinico Humanitas of Rozzano, Milan, Italy
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.04.169
Reference7 articles.
1. The EGFR as a target for anticancer therapy—focus on cetuximab
2. Epidermal growth factor receptor biology (IMC-C225)
3. Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor Inhibition
4. Paronychia induced by cetuximab, an antiepidermal growth factor receptor antibody
5. Contributions of the epidermal growth factor receptor to keratinocyte motility
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cutaneous Manifestation of Chemotherapeutic Agents;Complications of Cancer Therapy: Best Practices in Prevention and Management;2024
2. Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas;Journal of Neuro-Oncology;2020-09
3. Paronychia induced by the epidermal growth factor receptor inhibitor cetuximab;Journal of Oncology Pharmacy Practice;2012-11-16
4. Recommandations pour la pratique clinique: Nice, Saint-Paul de Vence 2009 « cancers du sein » et « soins de support »;Oncologie;2009-12
5. Evidence-Based Treatment Options for the Management of Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors;Annals of Pharmacotherapy;2009-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3